ArticleHuman genome variation2015

Pathway activation strength is a novel independent prognostic biomarker for cetuximab sensitivity in colorectal cancer patients.

Qingsong Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.